A Study to Evaluate the Accuracy of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-002042-36

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to evaluate the accuracy of a subset of the length-109 probe set panel in predicting mucosal healing (ie, improvement in the endoscopic appearance of the mucosa) at Week 6 as measured by AUCROC.


Critère d'inclusion

  • Moderately to severely active ulcerative colitis